WO2009113091A3 - Compositions pharmaceutiques contenant du valsartan - Google Patents

Compositions pharmaceutiques contenant du valsartan Download PDF

Info

Publication number
WO2009113091A3
WO2009113091A3 PCT/IN2009/000040 IN2009000040W WO2009113091A3 WO 2009113091 A3 WO2009113091 A3 WO 2009113091A3 IN 2009000040 W IN2009000040 W IN 2009000040W WO 2009113091 A3 WO2009113091 A3 WO 2009113091A3
Authority
WO
WIPO (PCT)
Prior art keywords
valsartan
pharmaceutical compositions
hydrochlorothiazide
preparation
disclosed
Prior art date
Application number
PCT/IN2009/000040
Other languages
English (en)
Other versions
WO2009113091A2 (fr
Inventor
Ashok Omray
Sandhya Rajendra Shenoy
Monika Srivastav
Original Assignee
Usv Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Usv Limited filed Critical Usv Limited
Publication of WO2009113091A2 publication Critical patent/WO2009113091A2/fr
Publication of WO2009113091A3 publication Critical patent/WO2009113091A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des compositions pharmaceutiques contenant du valsartan et, en option, des additifs pharmaceutiquement acceptable combinés à de l’hydrochlorothiazide. La présente invention concerne également un procédé de préparation associé.
PCT/IN2009/000040 2008-01-24 2009-01-13 Compositions pharmaceutiques contenant du valsartan WO2009113091A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN171MU2008 2008-01-24
IN171/MUM/2008 2008-01-24
IN1625/MUM/2008 2008-07-30
IN1625MU2008 2008-07-30

Publications (2)

Publication Number Publication Date
WO2009113091A2 WO2009113091A2 (fr) 2009-09-17
WO2009113091A3 true WO2009113091A3 (fr) 2010-01-21

Family

ID=40933991

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2009/000040 WO2009113091A2 (fr) 2008-01-24 2009-01-13 Compositions pharmaceutiques contenant du valsartan

Country Status (1)

Country Link
WO (1) WO2009113091A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011108762A1 (de) * 2011-07-28 2013-01-31 Stada Arzneimittel Ag Verpresste feste pharmazeutische Zusammensetzung, umfassend amorphes partikuläres Valsartan als Wirkstoff
CN103554047A (zh) * 2013-10-11 2014-02-05 镇江市高等专科学校 制备缬沙坦的方法
CN103893185B (zh) * 2014-04-23 2015-10-21 山东司邦得制药有限公司 一种缬沙坦氢氯噻嗪分散片及其制备方法
CN112999186A (zh) * 2021-03-04 2021-06-22 海南锦瑞制药有限公司 一种缬沙坦胶囊的制备方法和缬沙坦胶囊

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006066961A1 (fr) * 2004-12-24 2006-06-29 Krka, D.D., Novo Mesto Composition pharmaceutique solide comprenant du valsartan
US20070166372A1 (en) * 2006-01-19 2007-07-19 Mai De Ltd. Preparation of solid coprecipitates of amorphous valsartan
EP2067470A1 (fr) * 2007-12-03 2009-06-10 Laboratorios Lesvi, S.L. Compositions pharmaceutiques contenant du valsartan et procédé pour sa préparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006066961A1 (fr) * 2004-12-24 2006-06-29 Krka, D.D., Novo Mesto Composition pharmaceutique solide comprenant du valsartan
US20070166372A1 (en) * 2006-01-19 2007-07-19 Mai De Ltd. Preparation of solid coprecipitates of amorphous valsartan
EP2067470A1 (fr) * 2007-12-03 2009-06-10 Laboratorios Lesvi, S.L. Compositions pharmaceutiques contenant du valsartan et procédé pour sa préparation

Also Published As

Publication number Publication date
WO2009113091A2 (fr) 2009-09-17

Similar Documents

Publication Publication Date Title
IL275854A (en) Pharmaceutical composition and its administration
IL207569A0 (en) Compositions and methods for drug delivery
EP2419670B8 (fr) Procédé de distribution et compositions
HK1164292A1 (en) Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same
IL204521A0 (en) Oxadiazole derivatives, their preparation and pharmaceutical compositions containing them
IL205360A0 (en) Methods, kits, and compositions for administering pharmaceutical compounds
IL206395A (en) N- Heterocyclic-7-Oxo-6-Sulphoxy-6,1-Diazabicyclo [1.2.3] Octane-2-Carboxamides and Pharmaceuticals Containing Them
IL206952A (en) History of Aminodia Hydrothiazine, medicinal preparations containing them, and their use in the preparation of medicines
IL211391B (en) Benzo[d] oxazole-2-carboxamido-4-phenyl-thiophene-carboxylate derivatives, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
IL200206A (en) The history of quinaxaline, their preparation and their pharmaceutical preparations
IL206808A (en) Indolyl-pyridone history, their pharmaceutical preparations and their uses
IL216113A (en) Processed derivatives of indazole and azaza-indazole, pharmaceutical preparations containing them and their uses
IL206594A (en) The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations
IL195764A0 (en) Compositions and methods for drug delivery
ZA201100615B (en) Appetising medicament for oral administration in solid form
EP2211852A4 (fr) Compositions et procédés permettant de réduire l'hépatotoxicité associée à une administration médicamenteuse
EP2211851A4 (fr) Laminines, dérivés, compositions les contenant, et procédé pour leur utilisation thérapeutique
EP2241569A4 (fr) Composés de thiénopyridazine, leurs préparations, compositions pharmaceutiques et utilisations
IL212942A (en) History of Rifamycin, Methods of Preparation, Pharmaceutical Preparations Containing Them and Their Uses
IL217500A0 (en) Tetrazole derivatives, their preparartion and pharmaceutical compositions containing them
EP2386553A4 (fr) Dérivés de benzimidazole-4-carboxamide, leurs procédés d'élaboration, compositions pharmaceutiques et leurs utilisations
IL210316A (en) History of Triazol Pharmacopoeias that contain them and their uses
IL205710A (en) History of Spiro [Pipyridine-Benzopyran] Pharmaceuticals Containing Them, Methods of Preparing and Using Their @
EP2284158A4 (fr) Composés quinoline, compositions pharmaceutiques, procédés de préparation et utilisations associés
IL210377A0 (en) Naphthyridone derivatives, their preparation and pharmaceutical compositions conatining them

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09719880

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09719880

Country of ref document: EP

Kind code of ref document: A2